Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
University of Arkansas for Medical Sciences
Medical School - Teaching Hospital - Research Institution
The company in detail
Profile
The University of Arkansas for Medical Sciences (UAMS), the State's only comprehensive academic health center, consists of five colleges including Medicine and Pharmacy, a graduate school of biomedical sciences, six centers of excellence, and a Statewide network of regional healthcare centers. UAMS was founded in 1879 as a proprietary medical school by a group of eight physicians with 22 students and today houses over 2,500 students, 1,156 physicians and 733 medical residents and is part of the University of Arkansas System. UAMS pursues its' three-fold mission -- to teach, to search, to serve -- through graduate and post graduate programs in the various colleges. National Institutes of Health and other federal funding sources actively support clinical and translational research programs within the University involving medical, device and biotechnology research initiatives though programs in the University Hospital and its' affiliated clinics. UAMS sponsors basic and clinical research in broad areas of medicine and medical therapy. Traditionally strong research areas include Pharmacology and Toxicology; Cancer, Myeloma & Transplantation; Eye; Neuroscience; Pediatric Health; Aging & Gerontology and Psychiatry. The proprietary technologies from this research are actively captured for licensing opportunities and the delivery of better health. UAMS and its affiliates have an economic impact in Arkansas of over $5 billion a year. UAMS BioVentures serves as the Technology Licensing Office, spin-out business accelerator, and the portal to all of the University's intellectual property and economic development programs. For more information, please visit www.uams.edu/bioventures or contact Michael G. Douglas, PhD mdouglas@uams.edu or Charlie Cook at (501) 686-6696 – e-mail CACook@uams.edu
Partnering strategy/interests
The University of Arkansas for Medical Sciences, through its TLO UAMS BioVentures, is seeking global, commercial partners to out-license its' technology for the purpose of taking its discoveries to the world's medical and healthcare market places.
Out-licensing
Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More
Acute Renal Failure Target - Calcium Independent Phospholipase A2 More
Overexpressed in Werner's Syndrome Fibroblasts More
Overexpressed in Werner's Syndrome Fibroblasts More
Methods to Identify Genetic Predisposition to Alzheimer's disease More
Alzheimer's disease and other Neurodegenerative Conditions More
Prevention and novel treatment of cardiovascular conditions More
Protection against tissue injury from a variety of causes More
Timed release drug delivery More
Cardiovascular physiology and atherosclerosis - prevention of cardiovascular complications in patients with renal failure or increased carbamylation. More
Protein Targeting, Hypoallergenic Food Development, and Allergy More
Novel agents capable of reaching remote cellular sites More
Derivatives of Butyric Acid and Uses Thereof - treatment of autoimmune More
An immunoassay for the detection of CA125 utilizing the monoclonal antibodies More
Repeat Sequences of the CA125 Gene and Their Use for Diagnostic and Therapeutic Interventions More
Tumor Biology - Therapeutic sequestering tumor cells growth and diagnostic as a tumor specific marker More
Antileukoprotease (ALP) is overexpressed in low malignant, potential tumors and carcinomas More
Transmembrane Serine Protease Overexpressed in Ovarian Carcinoma More
RKT Signature Overexpressed in Ovarian Carcinoma More
Novel Secreted Serine Protease (TADG-14) Overexpressed in Ovarian and Breast Cancer More
Extracellular Serine Protease Overexpressed in Breast and Ovarian Carcinomas More
Diagnosis of functional heart disease and heart disease prognostication with emphasis on the multifractal alpha, the Levy flight analysis and the key discrete wavelet smoothing. More
Therapeutic agents for neurodegenerative disease, such as amyotrophic lateral sclerosis (ALS) More
Deriving a candidate vaccine strain for Chlamydia serovars More
Activation of Raf-1/MEK-1/2/p42MAPK Alone Is Sufficient to Induce LDL Receptor Expression More
P38MAPK Inhibitor for Elevation of Hepatic LDL Receptor Levels More
Therapy for ovarian and uterine cancer patients whose tumors have progressed or resisted chemotherapy. More
Application: Colposcopy - Foot-operated Focusing Device for Floor Stand Mounted Instruments More
Lung Function - Quantitative Measurement More
Improved efficiency and sensitivity for DNA analysis from formalin-fixed tissues and uses in kits for research and forensic pathology More
Molecular Cloning and Characterization of Cyclin G1 Binding Protein1 More
potent anti-tumor agents - Antineoplastic Activities of Ellipticine and Its Analogs More
Treatment of Skin and Epithelial Tumors Using Intralesional Injection of Combined Antigens More
Simple Animal Model for Infection More
non invasive in vivo detection of cells circulating in blood or lymphatic vessels More
Improvements in anticancer treatments More
Potential to extend the development of vaccines against previous unavailable HPV viral types. More
Generation of new vaccines against rare epitopes of HPV to block viral infection and prevent cervical cancer. More
Preventative vaccine, source of antigens for dendritic cell immunotherapy to treat cervical cancer More
Ophthalmologic Surgery More
Drug Delivery More
Dynamic treatment simulation software system for Intensity Modulated Radiation Therapy (IMRT) prior to the initiation of actual therapy More
A delivery system for siRNA type therapeutics More
An Endothelial lined Stent for Rapid Endothelialization and Preventing Restenosis More
Genetic cloning and sequencing of a novel IL-17 receptor-related gene More
Significant and predictive markers for multiple myeloma (MM) prognosis. More
Multiple hormone detection assay More
Novel diagnostic and prognostic gene array classification system More
Diagnostic marker profile for therapy monitoring and therapeutic targets in ovarian cancer More
Gene expression profiling to distinguish between cancerous tumors of the uterus verses the ovary More
Prognostic Test / Diagnostic Screening Multiple Myeloma and other cancers More
Non-primate animal model to several human infectious diseases More
Screening Methods for Compounds - Inhibit or Stimulate Helicase Enzyme Activity More
Expression of Genes in Heterologous Hosts More
Diagnostic and/or Therapeutic Tool to modulate cell development and function More
Novel Natural Killer Lytic Associated Protein Isolated Using DNA Encoding More
Inherent Healing Accelerator for Improved Large Wound Healing More
Comparative Gene Expression Profiles are Diagnostic for Improved Outcomes and Medical Management of Multiple Myeloma More
Screening compounds and model for the prevention of bone destruction More
Decreases bone fracture incidence More
Prevent the prometastic properties of certain cancer cells More
Enhanced cancer therapy More
Targets for novel anti-staphylococcal agents More
CTL capable of killing diseased or problematic cells More
Therapeutic methods to regulate excessive bone resorption More
Use of Human Protein C for Intraocular Fibrin and Inflammation Prevention More
Method and System for Image Pumping - software More
Method of Measuring by Gas Dilution Residual Lung Volume in Infants More
Growing mesenchymal stem cells that retain their undifferentiated properties More
Contrast agents for ultrasonic imaging, destruction of clots, ultrasound-induced permeability of blood vessels and other tissues, targeted drug delivery, or to enhance ultrasonic tissue ablation. More
precise and focused control of temperature mediated therapy and "triggering" deliverables in situ. More
Nutritional intervention to abrogate the adverse effects in diabetes-related pregnancy More
Qualitative diagnostic test for the presence of methamphetamine residue More
Methods for diagnosing, screening, prognosing and treating disease involving bone loss in humans. More
Analytical methods for screening new drug candidates More
identifying and quantifying specific HAT activity at the lysine being targeted by the HAT for covalent modification More
Ovarian cancer diagnostics More
Vaccine Ovarian Cancer More
Preservation of the beneficial immunosuppressive actions of glucocorticoid in the absence of deleterious effects on bone More
Rapidly (less than 24 hours) diagnose MOTT infections in humans or animals More
In-home device to induce cycling motion in patients who have little or no motor control of their legs - increasing muscle mass and decreasing hyperreflexia More
Laser Directed Portable MRI Stereotactic System More
Improved surgical procedures involving cancers of the liver or biliary tree, pancreatic and duodenal tumors, or liver transplantation More
Cancer therapeutic vaccine therapy More
Discloses the Promoter Sequence of Human Myo-D1 Gene and its Methylation Alteration in Tumorigenesis and Normal Development More
Application: Safer and More Efficient Gene Therapies More
SCID-hu mouse model More
A novel and simplified methodology for growth and analysis of biofunctions with applications in the fields of pharmocogenomics and neurodevelopment and neurotoxicology. More
Novel nonpalpable lesion detection procedure using hematoma - directed ultrasound and imaging. More
Vascular surgery and vascular grafts. More
Relax the smooth muscle and lower blood pressure More
Gene and/or protein therapy for Hepatitis C infection More
Increase in lifespan More
New Use Modafinil More
Novel Diagnostic and Therapeutic Marker - ovarian and endometrial cancers More
Treatment of Lytic Bone and other Diseases More
p49/STRAP is a Novel Protein Involved in Gene Regulation, Cardiac Development and Remodeling (04-20)
Regulation of key transcriptional elements in the development and aging of heart muscle More
Surgical device, a catheter that enables a connection between the pancreatic duct and small bowel. More
Abdominal surgical closure device More
Medical and dental uses of biocompatible nanofiber scaffolds More
Coronary Artery Bypass Graft (CABG) More
Organ transplantation More
Computerized decision making information system to direct the orders for patients sustaining multiple rib fractures. More
Ref: Molecular Microbiology (1999) 33, 1, 307-316 More
Balanced salt solution (BSS) audible alarm device More
Minimally Invasive Treatment of Breast Cancer More
Specific target or vaccine for cancer treatment and monitoring More
Ovarian cancer immunotherapy - therapeutic vaccine More
Screening tool for the detection of breast and other cancers More
New use of rapamycin to treat nephrogenic systemic fibrosis and scleroderma More
Prevention and repair of bone degeneration/fracture More
Method for Reducing Radiation Toxicity More
Mycobacterium Specific Tuberculosis Diagnostic Testing More
M. Tuberculosis Complex in Reverse Transcriptase-SDA Using Specific Nucleic Acid Sequence More
Detection of M. tuberculosis Complex via Reverse Transcriptase SDA More
Cancer - Novel Cell Surface Proteolytic Activity (Proteases) in Carcinogenic Tissues More
Accurate placement of catheter needles More
Infectivity Research Tool More
Pharmacology and medical therapeutics of statins More
Development and production of more potent vaccines against various antigens. More
Exogenous Type IV Collagen and combinations promote recovery of cellular function following sublethal toxic injury and renal disease More
Transplantation animal to human, organs, tissues, and cells. More
Deals
To view this information, you must subscribe to Partneringtools.
Press Releases
Head office
University of Arkansas for Medical Sciences
UAMS BioVentures
Technology Licensing Office
4301 West Markham Street #831
Little Rock
Arkansas
72205-7199
Arkansas
Tel: +1 501 686 6696
Fax: +1 501 686 8501
www | email
UAMS BioVentures
Technology Licensing Office
4301 West Markham Street #831
Little Rock
Arkansas
72205-7199
Arkansas
Tel: +1 501 686 6696
Fax: +1 501 686 8501
www | email
Contact details
Mr. Charles Cook
Licensing Associate
UAMS BioVentures - TLO
Licensing Associate
UAMS BioVentures - TLO
Company figures
Formed: 1879
Number of employees: 9600
Number of employees: 9600
Related categories
- Industry sector
- Drug delivery
- Biotech
- Biotechnology / Human diagnostics
- Biotechnology / Nanotechnology
- Biotechnology / Assay systems
- Biotechnology / Other
- Biotechnology / Human therapeutics
- Diagnostic / Imaging
- Diagnostic / Test systems
- Drug delivery
- Drug discovery
- Medical device
- Universities
- Pharmaceutical / Prescription
- Research tools
- Therapeutic target
- Accident and Trauma / Wound closure/surgical adhesive
- Cardiovascular
- Central Nervous System
- Central Nervous System / Neurological
- Central Nervous System / Age-related disorders (other)
- Central Nervous System / CNS (other)
- Central Nervous System / Neurodegenerative disorders
- Central Nervous System / Psychiatric
- Gastrointestinal
- Immune related disorders
- Oncology
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us